In charts | India’s COVID-19 case count, state-wise trends, vaccination data, and other key details

India reported 44,658 COVID-19 new cases, according to the August 27 update. Active infections up at 3.44 lakh mark; Over 79 lakh vaccine doses administered on Thursday, with over 61.22 crore doses administered till date.

Moneycontrol News

August 27, 2021 / 11:16 AM IST

File Image

India’s COVID-19 case tally is above 3.26 crore with 44,658 new cases reported, as per the health ministry’s August 27 update. As many as 496 new deaths were reported in the last 24 hours, new recoveries at 32,988 in the same period, the latest release showed.

Aug 27 Daily New Cases and Moving Avg

More than 61.22 crore vaccinations have been administered across India, according to the August 27 update, with 79,48,439 new vaccination doses administered on Thursday.

Aug 27_BarLine_Daily New Vaccination Vs Daily New Cases

Of the total vaccinations administered to date, 77 percent are recipients of their first dose while 23 percent have received the second dose. Among states, Uttar Pradesh administered the most (cumulative) vaccine doses at 6.68 crore, followed by Maharashtra at 5.53 crore and Gujarat at 4.46 crore.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show